CoChat

Duration and Severity of Symptoms and Levels of Plasma Interleukin-1 Receptor Antagonist, Soluble Tumor Necrosis Factor Receptor, and Adhesion Molecules in Patients with Common Cold Treated with Zinc Acetate

Prasad, Ananda S., Beck, Frances W. J., Bao, Bin, Snell, Diane, Fitzgerald, James T. · 2008 · The Journal of Infectious Diseases

The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Zinc lozenges have been used for treatment of the common cold; however, the results remain controversial. METHODS: Fifty ambulatory volunteers were recruited within 24 h of developing symptoms of the common cold for a randomized, double-blind, placebo-controlled trial of zinc. Participants took 1 lozenge containing 13.3 mg of zinc (as zinc acetate) or placebo every 2-3 h while awake. The subjective scores for common cold symptoms were recorded daily. Plasma zinc, soluble interleukin (IL)-1 receptor antagonist (sIL-1ra), soluble tumor necrosis factor receptor 1, soluble vascular endothelial cell adhesion molecule, and soluble intercellular adhesion molecule (sICAM)-1 were assayed on days 1 and 5. RESULTS: Compared with the placebo group, the zinc group had a shorter mean overall duration of cold (4.0 vs. 7.1 days; P < .0001) and shorter durations of cough (2.1 vs. 5.0 days; P < .0001) and nasal discharge (3.0 vs. 4.5 days, P = .02) Blinding of subjects was adequate, and adverse effects were comparable in the 2 groups. Symptom severity scores were decreased significantly in the zinc group. Mean changes in plasma levels of zinc, sIL-1ra, and ICAM-1 differed significantly between groups. CONCLUSION: Administration of zinc lozenges was associated with reduced duration and severity of cold symptoms. We related the improvement in cold symptoms to the antioxidant and anti-inflammatory properties of zinc.

Overview

Integrity signals

Registry

Crossref · 10.1086/528803

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Research works printed but not linked: 4

  1. Weismann E, 1990, Dan Med Bull, 37, 279
  2. 10.1001/jama.276.8.637 · doi:10.1001/jama.276.8.637 · Paper page
  3. Prasad AS, 1993, New York: Plenum, 279
  4. Beck FWJ, 1997, Am J Physiol, 272, E1002

Cited by

Items 101–121 of 121

Metadata

Authors
Prasad, A. S., Beck, F. W. J., Bao, B., Snell, D., & Fitzgerald, J. T.
Affiliations
  • Wayne State University (US)
  • University of Michigan (US)
Corresponding author
Prasad, Ananda S.
Venue
The Journal of Infectious Diseases
Published
2008-03-15
Volume
197
Issue
6
Pages
795-802
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2170919652
Cited by
121
References
30
Citations by year
2025: 5 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 6 · 2020: 11 · 2019: 5 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 15 · 2014: 8 · 2013: 6 · 2012: 9
FWCI
22.45
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
U.S. Public Health Service (5 R01 A150698-04)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Herbal Medicine Research Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords
common cold, zinc acetate, zinc lozenges, symptom duration, symptom severity, interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor 1, soluble ICAM-1, soluble VCAM-1, adhesion molecules, plasma zinc, antioxidant activity, anti-inflammatory activity, cough, rhinorrhea
MeSH terms
Adult, Common Cold, Double-Blind Method, Female, Humans, Male, Severity of Illness Index, Receptors, Tumor Necrosis Factor, Intercellular Adhesion Molecule-1, Zinc Acetate, Interleukin 1 Receptor Antagonist Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.